Form 4 for YCBD cbdMD, Inc.

Accepted 2025-05-08 00:00:00 ET · period of report 2025-05-06 · accession 0001437749-25-015501 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2025-05-08	2025-05-06	YCBD	Kennedy Thomas Ronan	CEO, CFO, Dir	C - Cnv Deriv	—	+67.9K	74.5K	+1,023%	—
D	2025-05-08	2025-05-06	YCBD	Kennedy Thomas Ronan	CEO, CFO, Dir	C - Cnv Deriv	—	-41.8K	0	-100%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-05-06	C	A	67,869	—	74,501	D	—	—	(F1) The 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") automatically converted into shares of common stock without any action on the part of the Reporting Person. The automatic conversion converts each share of the Preferred Stock into thirteen shares of the Company's common stock on May 6, 2025 at 4:01 p.m. Eastern Time. (F2) The price gives effect to the one-for-8 reverse stock split of the Company's issued and outstanding shares of common stock, effective May 6, 2025 at 4:02 p.m. Eastern Time.
2	Derivative	8% Series A Cumulative Convertible Preferred Stock	2025-05-06	C	D	41,765	—	0	D	— · — to —	67,869 Common Stock	(F3) Open market purchases. (F1) The 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") automatically converted into shares of common stock without any action on the part of the Reporting Person. The automatic conversion converts each share of the Preferred Stock into thirteen shares of the Company's common stock on May 6, 2025 at 4:01 p.m. Eastern Time. (F2) The price gives effect to the one-for-8 reverse stock split of the Company's issued and outstanding shares of common stock, effective May 6, 2025 at 4:02 p.m. Eastern Time.